Electroconvulsive therapy (ECT) is the most effective acute treatment for depression, but its use in younger patients is rare and heavily regulated in many U.S. states. It is unclear whether age modifies treatment response or tolerability in adolescents, transitional age youth, and young adults. We examined the effects of ECT on depression and cognition in patients aged 16–30 years.
Methods:
A retrospective cohort study of patients aged 16–30 years receiving ECT between 2011 and 2020 who were evaluated with the Quick Inventory of Depressive Symptomatology (QIDS), the Behavior and Symptom Identification Scale-24 (BASIS-24), and the Montreal Cognitive Assessment (MoCA) at baseline and following treatment #10.
Results:
Among the 424 patients who met the inclusion criteria, ECT was associated with a decrease in depression symptoms (ΔQIDS −6.7; Kruskal–Wallis rank sum test; χ2 = 293.37; df = 2; p < 0.0001) and improvement in overall self-reported mental health status (ΔBASIS-24 − 0.70; Kruskal–Wallis rank sum test; χ2 = 258.5; df = 2; p < 0.0001) during the first 10 treatments, with a slight reduction in cognition as measured by the MoCA (ΔMoCA −1.1; Kruskal–Wallis rank sum test; χ2 = 33.7; df = 1; p < 0.0001). Age was not a significant predictor of QIDS, BASIS-24, or MoCA changes.
Conclusions:
Among 424 patients aged 16–30 years receiving acute course ECT, age was not a significant predictor of improvement in depression, change in overall self-reported mental health status, or change in cognition. These results support the utility of ECT in the treatment of adolescents and young adults.
Get full access to this article
View all access options for this article.
References
1.
BahjiA, HawkenER, SepehryAA, CabreraCA, VazquezG: ECT beyond unipolar major depression: Systematic review and meta-analysis of electroconvulsive therapy in bipolar depression. Acta Psychiatr Scand, 139:214–226, 2019.
2.
BaumerFM, HoweM, GallelliK, SimeonovaDI, HallmayerJ, ChangKD: A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene. Biol Psychiatry, 60:1005–1012, 2006.
3.
BenderL: One hundred cases of childhood schizophrenia treated with electric shock. Trans Am Neurol Assoc, 72:165–169, 1947.
4.
BensonNM, SeinerSJ, BoltonP, FitzmauriceG, MeisnerRC, PierceC, BuschAB: Acute phase treatment outcomes of electroconvulsive therapy in adolescents and young adults. J ECT, 35:178–183, 2019.
5.
BrentD, EmslieG, ClarkeG, WagnerKD, AsarnowJR, KellerM, VitielloB, RitzL, IyengarS, AbebeK, BirmaherB, RyanN, KennardB, HughesC, DeBarL, McCrackenJ, StroberM, SuddathR, SpiritoA, LeonardH, MelhemN, PortaG, OnoratoM, ZelaznyJ: Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. JAMA, 299:901–913, 2008.
6.
CohenD, TaiebO, FlamentM, BenoitN, ChevretS, CorcosM, FossatiP, JeammetP, AllilaireJ-F, BasquinM: Absence of cognitive impairment at long-term follow-up in adolescents treated with ECT for severe mood disorder. Am J Psychiatry, 157:460–462, 2000.
7.
Committ APA, Weiner RD: Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training, and Privileging. Washington, DC, American Psychiatric Publishing, Inc., 2001.
8.
CostaAS, FimmB, FriesenP, SoundjockH, RottschyC, GrossT, EitnerF, ReichA, SchulzJB, NasreddineZS, ReetzK: Alternate-form reliability of the Montreal cognitive assessment screening test in a clinical setting. Dement Geriatr Cogn Disord, 33:379–384, 2012.
9.
CousinsL, GoodyerIM: Antidepressants and the adolescent brain. J Psychopharmacol Oxf Engl, 29:545–555, 2015.
10.
de la SernaE, FlamariqueI, Castro-FornielesJ, PonsA, PuigO, Andrés-PerpiñaS, LázaroL, GarridoJM, BernardoM, BaezaI: Two-year follow-up of cognitive functions in schizophrenia spectrum disorders of adolescent patients treated with electroconvulsive therapy. J Child Adolesc Psychopharmacol, 21:611–619, 2011.
11.
DierckxB, HeijnenWT, van den BroekWW, BirkenhägerTK: Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: A meta-analysis. Bipolar Disord, 14:146–150, 2012.
12.
EisenSV, GerenaM, RanganathanG, EschD, IdicullaT: Reliability and validity of the BASIS-24 Mental Health Survey for Whites, African-Americans, and Latinos. J Behav Health Serv Res, 33:304–323, 2006.
13.
GhaziuddinN, DhosscheD, MarcotteK: Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatr Scand, 125:33–38, 2012.
14.
GhaziuddinN, KutcherSP, KnappP: Practice parameter for use of electroconvulsive therapy with adolescents. J Am Acad Child Adolesc Psychiatry, 43:1521–1539, 2004.
15.
GhaziuddinN, LaughrinD, GiordaniB: Cognitive side effects of electroconvulsive therapy in adolescents. J Child Adolesc Psychopharmacol, 10:269–276, 2000.
16.
GieddJN: The teen brain: Insights from neuroimaging. J Adolesc Health Off Publ Soc Adolesc Med, 42:335–343, 2008.
17.
HemphillRE, WalterWG: The treatment of mental disorders by electrically induced convulsions. J Ment Sci, 87:256–275, 1941.
18.
HeuyerG, BourRL: L'électro-choc chez les enfants (Electroshock in children). Ann Méd-Psychol, 101:402–407, 1943.
19.
JosephMF, YoungstromEA, SoaresJC: Antidepressant-coincident mania in children and adolescents treated with selective serotonin reuptake inhibitors. Future Neurol, 4:87–102, 2008.
20.
KarayagmurluA, CoskunM, ElbogaG, GhaziuddinN, KarayagmurluE, GökçenC, AltindagA: Efficacy and safety of electroconvulsive therapy in adolescents: A retrospective chart review study from Turkey. J ECT, 36:54–59, 2020.
21.
LandryM, MorenoA, PatryS, PotvinS, LemassonM: Current practices of electroconvulsive therapy in mental disorders: A systematic review and meta-analysis of short and long-term cognitive effects. J ECT, 37:119–127, 2021.
22.
LewandowskiRE, AcriMC, HoagwoodKE, OlfsonM, ClarkeG, GardnerW, ScholleSH, ByronS, KelleherK, PincusHA, FrankS, HorwitzSM: Evidence for the management of adolescent depression. Pediatrics, 132:e996–e1009, 2013.
23.
LivingstonR, WuC, MuK, CoffeyMJ: Regulation of electroconvulsive therapy: A systematic review of US state laws. J ECT, 34:60, 2018.
24.
LuccarelliJ, HenryME, McCoyTH: Demographics of patients receiving electroconvulsive therapy based on state-mandated reporting data. J ECT, 36:229–233, 2020a.
25.
LuccarelliJ, McCoyTH, SeinerSJ, HenryME: Charge required to induce a seizure during initial dose titration using right unilateral brief pulse electroconvulsive therapy. Brain Stimul Basic Transl Clin Res Neuromodulation, 13:1504–1506, 2020b.
26.
LuccarelliJ, McCoyTHJ, SeinerSJ, HenryME: Total charge required to induce a seizure in a retrospective cohort of patients undergoing dose titration of right unilateral ultrabrief pulse electroconvulsive therapy. J ECT, 37:40–45, 2021a.
27.
LuccarelliJ, McCoyTH, ShannonAP, ForesterBP, SeinerSJ, HenryME: Rate of continuing acute course treatment using right unilateral ultrabrief pulse electroconvulsive therapy at a large academic medical center. Eur Arch Psychiatry Clin Neurosci, 271:191–197, 2021b.
28.
LuccarelliJ, McCoyTHJ, ShannonAP, ForesterBP, SeinerSJ, HenryME: Duration of treatment in electroconvulsive therapy among patients beginning with acute course right unilateral brief pulse stimuli. J ECT 2021c.
29.
MoirandR, GalvaoF, LecompteM, PouletE, HaesebaertF, BrunelinJ: Usefulness of the Montreal Cognitive Assessment (MoCA) to monitor cognitive impairments in depressed patients receiving electroconvulsive therapy. Psychiatry Res, 259:476–481, 2018.
30.
NasreddineZS, PhillipsNA, BédirianV, CharbonneauS, WhiteheadV, CollinI, CummingsJL, ChertkowH: The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc, 53:695–699, 2005.
31.
PufferCC, WallCA, HuxsahlJE, FryeMA: A 20 year practice review of electroconvulsive therapy for adolescents. J Child Adolesc Psychopharmacol, 26:632–636, 2016.
32.
ReyJM, WalterG: Half a century of ECT use in young people. Am J Psychiatry, 154:595–602, 1997.
33.
RushAJ, TrivediMH, IbrahimHM, CarmodyTJ, ArnowB, KleinDN, MarkowitzJC, NinanPT, KornsteinS, ManberR, ThaseME, KocsisJH, KellerMB: The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): A psychometric evaluation in patients with chronic major depression. Biol Psychiatry, 54:573–583, 2003.
34.
SemkovskaM, McLoughlinDM: Objective cognitive performance associated with electroconvulsive therapy for depression: A systematic review and meta-analysis. Biol Psychiatry, 68:568–577, 2010.
35.
SocciC, MeddaP, ToniC, LattanziL, TripodiB, VannucchiG, PerugiG: Electroconvulsive therapy and age: Age-related clinical features and effectiveness in treatment resistant major depressive episode. J Affect Disord, 227:627–632, 2018.
36.
TanHH, XuJ, TeohHL, ChanBP-L, SeetRCS, VenketasubramanianN, SharmaVK, ChenCL-H, DongY: Decline in changing Montreal Cognitive Assessment (MoCA) scores is associated with post-stroke cognitive decline determined by a formal neuropsychological evaluation. PLoS One, 12:e0173291, 2017.
37.
ThompsonJW, BlaineJD: Use of ECT in the United States in 1975 and 1980. Am J Psychiatry, 144:557–562, 1987.
38.
VieiraIS, FerrugemSCR, ReyesAN, BrancoJC, MondinTC, Cardoso T deA, KapczinskiF, Souza LD deM, JansenK, da SilvaRA, Pedrotti MoreiraF: Effects of depression and excess body weight on cognition and functioning in young adults: A population-based study. J Affect Disord, 282:401–406, 2021.
39.
WeissA, HussainS, NgB, SarmaS, TillerJ, WaiteS, LooC: Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the administration of electroconvulsive therapy. Aust N Z J Psychiatry, 53:609–623, 2019.
40.
WilensTE, RosenbaumJF: Transitional aged youth: A new frontier in child and adolescent psychiatry. J Am Acad Child Adolesc Psychiatry, 52:887–890, 2013.
41.
WilliamsJ, ChiuL, LivingstonR: Electroconvulsive therapy (ECT) and race: A report of ECT use and sociodemographic trends in Texas. J ECT, 33:111–116, 2017.
42.
WuC-Y, HungS-J, LinK, ChenK-H, ChenP, TsayP-K: Responsiveness, minimal clinically important difference, and validity of the MoCA in stroke rehabilitation. Occup Ther Int, 2019:2517658, 2019.
43.
ZisookS, LesserI, StewartJW, WisniewskiSR, BalasubramaniG k., FavaM, GilmerWS, DresselhausTR, ThaseME, NierenbergAA, TrivediMH, RushAJ: Effect of age at onset on the course of major depressive disorder. Am J Psychiatry, 164:1539–1546, 2007.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
